{
    "code": "02020452",
    "time": "2015-08-07 03:27:20",
    "許可證字號": "衛署藥輸字第020452號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "有效日期": "108\/05\/18",
    "發證日期": "83\/05\/18",
    "許可證種類": "製　劑",
    "舊證字號": "",
    "醫療器材級數": "",
    "通關簽審文件編號": "DHA00202045201",
    "中文品名": "達利全錠25毫克",
    "英文品名": "DILATREND TABLETS 25MG",
    "適應症": "高血壓、鬱血性心臟衰竭。",
    "劑型": "110錠劑",
    "包裝": "盒裝",
    "藥品類別": "06須由醫師處方使用",
    "管制藥品分類級別": "",
    "主成分略述": "CARVEDILOL",
    "限制項目": [
        "02輸入"
    ],
    "申請商名稱": "1901701100  羅氏大藥廠股份有限公司",
    "申請商地址": "台北市民生東路三段１３４號９樓",
    "主製造廠": {
        "製造廠名稱": "F250342000  ROCHE SPA",
        "製造廠廠址": "VIA MORELLI 2, SEGRATE(MI), ITALIA",
        "製造廠公司地址": "",
        "製造廠國別": "ITALY",
        "製程": ""
    },
    "CCC號列": "30049099904 其他醫藥製劑〈不包括第３００２、３００５或３００６節所列者〉包含經混合或未混合產品供治療或預防疾病用，具有劑量（包括經皮給藥形態者）或零售包裝式樣者Other medicaments (excluding goods of heading 30.02, 30.05 or 30.06) consisting of mixed or unmixed products for therapeutic or prophylactic uses,put up in measured doses or in forms or packings for retail sale",
    "藥理治療分類": "",
    "次製造廠": [
        {
            "製造廠名稱": "F430208000  F.HOFFMANN-LA ROCHE LTD.",
            "製造廠廠址": "WURMISWEG, CH-4303 KAISERAUGST, SWITZERLAND",
            "製造廠公司地址": "",
            "製造廠國別": "SWITZERLAND",
            "製程": ""
        }
    ],
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "1210100100",
            "成分名稱": "CARVEDILOL",
            "含量描述": "",
            "含量": "25.0000000000",
            "單位": "MG"
        }
    ],
    "藥物辨識詳細資料": {
        "外觀尺寸": "",
        "特殊劑型": "",
        "顏色": "白色",
        "特殊氣味": "",
        "刻痕": "",
        "形狀": "圓扁形",
        "標記一": "B,M",
        "標記二": "D,5"
    },
    "藥物辨識外觀圖片": [
        {
            "title": "圖片",
            "url": "http:\/\/www.fda.gov.tw\/MLMS\/(S(knoy1cz5iwyfatvvguaez0re))\/ShowFile.aspx?LicId=02020452&Seq=426&Type=10"
        }
    ],
    "仿單外盒": [
        {
            "title": "仿單 020204520001-104-07-22.pdf 20121122_RSI_1_Response 2 English PI___20121203.pdf 20121122_RSI_1_Response 2 Chinese PI___20121203.pdf 020204520028___20110121.pdf 020204520027.jpg 020204520026.jpg 020204520025.jpg 020204520024.jpg 020204520023.jpg 020204520022.jpg 020204520021.jpg 020204520020.jpg 020204520019.jpg 020204520018.jpg 020204520017.jpg 020204520016.jpg 020204520015.jpg 020204520014.jpg 020204520013.jpg 020204520012.jpg 020204520011.jpg 020204520010.jpg 020204520009.jpg 020204520008.jpg 020204520007.jpg 020204520006.jpg 020204520005.jpg 020204520004.jpg 020204520003.jpg 020204520002.jpg 020204520001.doc",
            "url": "http:\/\/www.fda.gov.tw\/MLMS\/(S(knoy1cz5iwyfatvvguaez0re))\/ShowFile.aspx?LicId=02020452&Seq=031&Type=9"
        },
        {
            "title": "外盒 20121122_RSI_1_Response 2 FB___20121203.pdf 20121122_RSI_1_Response 2 Chinese Label___20121203.pdf 20121122_RSI_1_Response 2 Blister___20121203.pdf 020204520002___20110121.pdf 020204520001___20110121.pdf",
            "url": "http:\/\/www.fda.gov.tw\/MLMS\/(S(knoy1cz5iwyfatvvguaez0re))\/ShowFile.aspx?LicId=02020452&Seq=005&Type=8"
        }
    ]
}